Helen M. Thackray

Helen M. Thackray has an estimated net worth of $3.88 Million. This is based on reported shares across multiple companies, which include ImmunoGen, Inc., BIOCRYST PHARMACEUTICALS INC, and GLYCOMIMETICS INC.

2021 was Helen M. Thackray's most active year for acquiring shares with 8 total transactions. Helen M. Thackray's most active month to acquire stocks was the month of December. 2024 was Helen M. Thackray's most active year for disposing of shares, totalling 9 transactions. Helen M. Thackray's most active month to dispose stocks was the month of January. 2021 saw Helen M. Thackray paying a total of $262,680.00 for 926,500 shares, this is the most they've acquired in one year. In 2022 Helen M. Thackray cashed out on 10,725 shares for a total of $157,151.25, their largest year based on trade value.